BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

Journal of Experimental Medicine

Volumn 189, Issue 11, 1999, Pages 1747-1756

  Schneider, Pascal ^a   Mackay, Fabienne ^e   Steiner, Véronique ^a   Hofmann, Kay ^b   Bodmer, Jean Luc ^a   Holler, Nils ^a   Ambrose, Christine ^e   Lawton, Pornsri ^e   Bixler, Sarah ^e   Acha Orbea, Hans ^a   Valmori, Danila ^c   Romero, Pedro ^c   Werner Favre, Christiane ^d   Zubler, Rudolph H ^d   Browning, Jeffrey L ^e   Tschopp, Jürg ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e Biegen Inc   (United States)

Author keywords

B cell growth; B lymphocytes; Immunoglobulin G; T lymphocytes; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR;

ARTICLE; B LYMPHOCYTE; ENZYME SPECIFICITY; GROWTH STIMULATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; BASE SEQUENCE; CELL DIVISION; CELL LINE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; CLONING, MOLECULAR; DENDRITIC CELLS; DNA PRIMERS; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; RECEPTORS, TUMOR NECROSIS FACTOR; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033532634     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.11.1747     Document Type: Article

References (39)

1. Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF-receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:959-962.
2. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Ref. Immunol. 10:411-452.
3. De Togni, P., J. Goellner, N.H. Ruddle, P.R. Streeter, A. Pick, S. Mariathasan, S.C. Smith, R. Carlson, L.P. Shornick, J. Strauss-Schoenberger, et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 264:703-707.
4. Koni, P.A., R. Sacca, P. Lawton, J.L. Browning, N.H. Ruddle, and R.A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity, 6:491-500.
5. Amakawa, R., A. Hakem, T.M. Kundig, T. Matsuyama, J.J. Simard, E. Timms, A. Wakeham, H.W. Mittruecker, H. Griesser, H. Takimoto, et al. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell. 84:551-562.
6. Russell, J.H., B. Rush, C. Weaver, and R. Wang. 1993. Mature T cells of the autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA. 90: 4409-4413.
7. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature. 377:348-351.
8. van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330-337.
9. Stuber, E., and W. Strober. 1996. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183:979-989.
10. Schneider, P., J.L. Bodmer, N. Holler, C. Mattmann, P. Scuderi, A. Terskikh, M.C. Peitsch, and J. Tschopp. 1997. Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J. Biol. Chem. 272:18827-18833.
11. Hahne, M., T. Kataoka, M. Schroter, K. Hofmann, M. Irmler, J.L. Bodmer, P. Schneider, T. Bornand, N. Holler, L.E. French, et al. 1998. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188:1185-1190.
12. Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L.E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, et al. 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science. 274:1363-1366.
13. Grimaitre, M., C. Werner-Favre, V. Kindler, and R.H. Zubler. 1997. Human naive B cells cultured with EL-4 T cells mimic a germinal center-related B cell stage before generating plasma cells. Concordant changes in Bcl-2 protein and messenger RNA levels. Eur. J. Immunol. 27:199-205.
14. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.L. Bodmer, M. Schroter, et al. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:517-521.
15. Schneider, P., N. Holler, J.L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205-1213.
16. Matsudaira, P. 1987. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262:10035-10038.
17. Armitage, R.J., W.C. Fanslow, L. Strockbine, T.A. Sato, K.N. Clifford, B.M. Macduff, D.M. Anderson, S.D. Gimpel, T. Davis-Smith, C.R. Maliszewski, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature. 357:80-82.
18. Bucher, P., K. Karplus, N. Moeri, and K. Hofmann. 1996. A flexible search technique based on generalized profiles. Comp. Chem. 20:3-23.
19. Banner, D.W., A. D'Arcy, W. Janes, R. Gentz, H.J. Schoenfeld, C. Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell. 73:431-445.
20. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
21. Black, R.A., C.T. Rauch, C.J. Kozlosky, J.J. Peschon, J.L. Slack, M.F. Wolfson, B.J. Castner, K.L. Stocking, P. Reddy, S. Srinivasan, et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 385: 729-733.
22. Wong, R., J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F. Bartlett, W. Frankel, et al. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:25190-25194.
23. Kindler, V., and R.H. Zubler. 1997. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J. Immunol. 159:2085-2090.
24. Berger, R., M. Le Coniat, J. Derre, and D. Vecchione. 1989. Secondary nonrandom chromosomal abnormalities of band 13q34 in Burkitt lymphoma-leukemia. Genes Chromosomes Cancer. 1:115-118.
25. Magrath, I. 1990. The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 55:133-270.
26. Chicheportiche, Y., P.R. Bourdon, H. Xu, Y.M. Hsu, H. Scott, C. Hession, I. Garcia, and J.L. Browning. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272: 32401-32410.
27. Nakayama, K. 1997. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327:625-635.
28. Hodgkin, P.D., and A. Basten. 1995. B cell activation, tolerance and antigen-presenting function. Curr. Opin. Immunol. 7:121-129.
29. Dubois, B., B. Vanbervliet, J. Fayette, C. Massacrier, C. Van Kooten, F. Briere, J. Banchereau, and C. Caux. 1997. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185:941-951.
30. Garside, P., E. Ingulli, R.R. Merica, J.G. Johnson, R.J. Noelle, and M.K. Jenkins. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science. 281: 96-99.
31. MacLennan, I.C., A. Gulbranson-Judge, K.M. Toellner, M. Casamayor-Palleja, E. Chan, D.M. Sze, S.A. Luther, and H.A. Orbea. 1997. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev. 156:53-66.
32. Grewal, I.S., and R.A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.
33. Armitage, R.J., and M.R. Alderson. 1995. B-cell stimulation. Curr. Opin. Immunol. 7:243-247.
34. Blanchard, D., C. Gaillard, P. Hermann, and J. Banchereau. 1994. Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth. Eur. J. Immunol. 24:330-335.
35. Shanebeck, K.D., C.R. Maliszewski, M.K. Kennedy, K.S. Picha, C.A. Smith, R.G. Goodwin, and K.H. Grabstein. 1995. Regulation of murine B cell growth and differentiation by CD30 ligand. Eur. J. Immunol. 25:2147-2153.
36. Schrader, C.E., J. Stavnezer, H. Kikutani, and D.C. Parker. 1997. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig. J. Immunol. 158:153-162.
37. Gruss, H.J., and S.K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood. 85:3378-3404.
38. Tsubata, T., J. Wu, and T. Honjo. 1993. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature. 364:645-648.
39. Arpin, C., J. Dechanet, C. Van Kooten, P. Merville, G. Grouard, F. Briere, J. Banchereau, and Y.J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science. 268:720-722.